Winrevair (sotatercept-csrk), an injection therapy approved for adults with pulmonary arterial hypertension (PAH), is now covered by several…
Articles by Marisa Wexler, MS
Measuring levels of tiny pieces of genetic material in the blood, known as microRNAs, may help identify group 2…
A study found that a naturally occurring signaling molecule called C-type natriuretic peptide (CNP) reduced the severity of pulmonary…
Cereno Scientific has been cleared to launch a Phase 1 clinical trial in Sweden to evaluate the pharmacological properties…
People with pulmonary arterial hypertension (PAH) often have abnormalities in the coronary microvasculature, or the tiny blood vessels…
Following positive results from a Phase 3 clinical study, United Therapeutics plans to submit an application to the U.S.
GSK (formerly called GlaxoSmithKline) has acquired rights to HS235, an experimental treatment for pulmonary hypertension (PH), now…
Global advocacy group Phaware has launched a new app, called…
People with pulmonary arterial hypertension (PAH) who were treated with the inhaled therapy seralutinib in a clinical trial tended…
In pulmonary arterial hypertension (PAH), blood vessel cells in the lungs release exosomes, or cellular shipping containers, filled with…
Treatment with molecular shipping containers called extracellular vesicles, loaded with a signaling molecule called cAMP, reduced the severity of…
Mutations in the gene SOX17 are linked to a severe form of pulmonary arterial hypertension (PAH) that most often manifests…